RecruitingRecruiting
ALS Research Collaborative
NCT06885918 · ALS Therapy Development Institute
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
ALS Translational Research Program
About this study
The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND), a known mutation related to ALS and healthy volunteers contribute prospective and retrospective data to this study remotely. The study is sponsored and conducted by the ALS Therapy Development Institute.
Eligibility criteria
Inclusion Criteria:
* 18 years of age or older
* Can communicate in written English
* Has a diagnosis of ALS/MND or is a known carrier of an ALS associated mutation
Exclusion Criteria:
* Significant cognitive impairment that would prevent individual completion and understanding of the informed consent process.
Study design
Enrollment target: 2000 participants
Age groups: adult, older_adult
Timeline
Starts: 2014-09-12
Estimated completion: 2035-01-31
Last updated: 2025-03-20
Primary outcomes
- • ALS Functional Rating Scale - Revised (ALSFRS-R) (Monthly, through study completion, an average of 1 year)
Sponsor
ALS Therapy Development Institute · other
Contacts & investigators
ContactAlan S Premasiri, M.S. · contact · apremasiri@als.net · 617-441-7200
ContactBeth Levine · contact · blevine@als.net · 617-441-7200
InvestigatorFernando G Vieira, M.D. · principal_investigator, ALS Therapy Development Institute
All locations (1)
ALS Therapy Development InstituteRecruiting
Watertown, Massachusetts, United States